PREPARED FOODSTUFFS > MISCELLANEOUS EDIBLE PREPARATIONS > Food preparations not elsewhere specified or included > Other > Other > Containing no milkfats, sucrose, isoglucose, glucose or starch or containing, by weight, less than 1,5|% milkfat, 5|% sucrose or isoglucose, 5|% glucose or starch
Product samples
11. In this Section the term 'pellets' means products which have been agglomerated either directly by compression or by the addition of a binder in a proportion not exceeding 3 % by weight. 2. The expression 'food preparations' in this Section, unless the context otherwise requires, means preparations classified in headings 1601 to 2106.
Source: European Commission - CN Explanatory Notes (CNEN) and HS legal notes.
2019/1661
Pale yellow liquid product composed of 93% ethyl esters of fatty acids and 7% oligomers and partial glycerides, resulting from the treatment (refining, hydrolysis, ethyl esterification, fractionation) of fish oils (anchovy, sardine, mackerel). The triglycerides are fully converted into ethyl esters. Intended for industrial food processing, animal feed, or pharmaceutical sector, this intermediate product is packaged under protective atmosphere in 190 kg drums. It falls under the category of industrial preparations based on fatty acids, subject to regulations on raw materials and/or additives, as well as traceability requirements for marine origin and health safety.
2019/921
Product in the form of tablets containing 400 mg of S-adenosyl-L-methionine disulfate p-toluenesulfonate (SAMe) as the active substance, accompanied by excipients (microcrystalline cellulose, magnesium hydroxide, stearic acid, magnesium stearate, anhydrous colloidal silica, calcium oxide, coating). Intended for use as a dietary supplement to support liver function, detoxification, and emotional health, with a recommended dose of one tablet per day and supplied in bulk. Falls under the regulation on dietary supplements (Directive 2002/46/EC), with requirements for labeling, traceability, active substance safety, and health claims.
2019/922
Customs classification of this product, intended for human consumption as a dietary supplement, must be based on its essential character and composition. The product is a bulk form of fine beige granules containing white particles, composed notably of amino acids (methionine, cystine), vitamins (B group), plant extracts, yeast, and mineral complexes, with excipients. It is designed to be homogenized and then encapsulated, and marketed as a dietary supplement claiming to combat hair loss, improve skin, and strengthen nails. According to the General Rules of Interpretation (RGI), the product's essential character is determined by its main functional component, which appears to be the amino acids and vitamins. The product is a food supplement falling under the scope of Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and other substances to foods, and must comply with safety requirements for substances, excipients, and traceability. The classification should be made under the appropriate heading of the Combined Nomenclature (CN), considering the product's nature, composition, and intended use, with reference to the relevant legal provisions, including Regulation 2019/922.
C-441/15
9 Feb 2017Madaus GmbH v Hauptzollamt Bremen
Judgment of the Court (Eighth Chamber) of 9 February 2017.#Madaus GmbH v Hauptzollamt Bremen.#Reference for a preliminary ruling — Common Customs Tariff — Tariff classification — Combined Nomenclature — Headings 3824 90 97 and 2106 90 92 — Product in powder form composed of calcium carbonate (95%) and modified starch (5%).#Case C-441/15.
C-700/15
15 Dec 2016LEK Farmacevtska Družba d.d. v Republika Slovenija
Judgment of the Court (Sixth Chamber) of 15 December 2016.#LEK Farmacevtska Družba d.d. v Republika Slovenija.#Reference for a preliminary ruling — Combined Nomenclature — Classification of goods — Food supplements falling under heading 2106 — Active ingredient as the essential component — Possible classification in Chapter 30 of the Combined Nomenclature — Goods presented and marketed as medicinal products.#Case C-700/15.
€0
€0
+€0
€6.27/kg
€7.34/kg
2,291
ModerateThird-country sourcing partners
| # | Partner | Value (EUR) | kg | €/kg | Share | YoY |
|---|---|---|---|---|---|---|
| 1 | 🇬🇧 United Kingdom | €1.8B | 150.3Mt | €12.00/kg | 30.7% | |
| 2 | 🇺🇸 United States | €1.6B | 59.2Mt | €26.96/kg | 27.2% | |
| 3 | 🇨🇳 China | €1.0B | 106.1Mt | €9.69/kg | 17.5% | |
| 4 | 🇨🇭 Switzerland | €745.7M | 68.5Mt | €10.89/kg | 12.7% | |
| 5 | 🇹🇷 Turkey | €700.0M | 85.3Mt | €8.21/kg | 11.9% |
Third-country target markets
| # | Partner | Value (EUR) | kg | €/kg | Share | YoY |
|---|---|---|---|---|---|---|
| 1 | 🇬🇧 United Kingdom | €2.1B | 480.5Mt | €4.29/kg | 34.4% | |
| 2 | 🇺🇸 United States | €1.6B | 128.4Mt | €12.70/kg | 27.2% | |
| 3 | 🇨🇭 Switzerland | €951.9M | 78.6Mt | €12.11/kg | 15.9% | |
| 4 | 🇷🇺 Russia | €679.4M | 55.0Mt | €12.36/kg | 11.3% | |
| 5 | 🇨🇳 China | €675.0M | 28.6Mt | €23.61/kg | 11.3% |